Target intelligence / Profile preview

Potassium channel tetramerization domain containing 9 (KCTD9)

Target
KCTD9
Molecular classification
Other (acts as a substrate-adapter protein), Often classified within BTB/POZ domain-containing proteins (not a true ion channel or receptor itself)
01

Overview

Potassium channel tetramerization domain containing 9 is a cytoplasmic protein encoded by the KCTD9 gene, broadly related to the larger family of proteins with potassium channel tetramerization domains, which participate in assembly and molecular regulation of tetrameric channel complexes[2][3][6]. KCTD9 is not itself a potassium channel or a canonical receptor; rather, it serves as a substrate-specific adaptor within a BTB-CUL3-RBX1 E3 ubiquitin ligase complex, promoting ubiquitination and proteasomal degradation of specific cellular proteins[3]. It's implicated in intracellular signal transduction, immune cell function (particularly natural killer cell activation and lineage commitment), and may play roles in neuronal function and response to viral infection[3]. Disease associations include certain forms of neuronal ceroid lipofuscinosis, but so far there are no approved drugs targeting this protein, nor is it used as a biomarker in clinical practice[3][6]. If you require further molecular or pathway specifics, or details on experimental models (e.g., mouse homologs), those are documented in resources such as GeneCards and Mouse Genome Informatics[3][5].

Other names
KCTD9potassium channel tetramerisation domain containing 9
02

Biological functions

Protein ubiquitination (as an adapter for BTB-CUL3-RBX1 E3 ubiquitin ligase complex; mediates degradation of target proteins)Intracellular signal transductionProtein homooligomerizationNK cell activation and lineage commitment (predicted)Response to viral infection (predicted)
03

Disease associations

Neurodegenerative disease (associated with ceroid lipofuscinosis forms)Other (predicted to be involved in immune response pathways)

Beyond the preview

Go deeper on Potassium channel tetramerization domain containing 9 (KCTD9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium channel tetramerization domain containing 9 (KCTD9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call